These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8400317)
1. Urinary testosterone as a marker of risk of recurrence in operable breast cancer. Ballerini P; Oriana S; Duca P; Martinetti A; Venturelli E; Ferrari L; Dolci S; Secreto G Breast Cancer Res Treat; 1993; 26(1):1-6. PubMed ID: 8400317 [TBL] [Abstract][Full Text] [Related]
2. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851 [TBL] [Abstract][Full Text] [Related]
3. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. Secreto G; Zumoff B Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646 [TBL] [Abstract][Full Text] [Related]
4. MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma. Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T Breast Cancer Res Treat; 1999 Dec; 58(3):287-93. PubMed ID: 10718490 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer. Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N; Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673 [TBL] [Abstract][Full Text] [Related]
7. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511 [TBL] [Abstract][Full Text] [Related]
8. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup. Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499 [TBL] [Abstract][Full Text] [Related]
9. Testosterone levels as a marker of prognosis to goserelin treatment in metastatic breast cancer. Secreto G; Boracchi P; Buzzoni R; Venturelli E; Cavalleri A; Dolci S Eur J Cancer; 1994; 30A(11):1629-31. PubMed ID: 7833135 [TBL] [Abstract][Full Text] [Related]
10. Breast conservation treatment of early stage breast cancer: patterns of failure. Leborgne F; Leborgne JH; Ortega B; Doldan R; Zubizarreta E Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):765-75. PubMed ID: 7860387 [TBL] [Abstract][Full Text] [Related]
11. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients. Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
14. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA; JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844 [TBL] [Abstract][Full Text] [Related]
15. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712 [TBL] [Abstract][Full Text] [Related]
16. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609 [TBL] [Abstract][Full Text] [Related]
17. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution. Yang Y; He Y; Fan Z; Ouyang T Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
20. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]